Evidence map›Paper›PMID 33531866›Full record

ArticleContemporary oncology (Poznan, Poland)2020

Proinflammatory cytokines and colorectal cancer - the impact of the stage.

Lyudmila Akhmaltdinova, Valentina Sirota, Dmitriy Babenko, Vera Zhumaliyeva, Irina Kadyrova, Mereke Maratkyzy, Aigerim Ibrayeva, Olga Avdienko

Open access · goldAbstract read
In one paragraph

Article in Contemporary oncology (Poznan, Poland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Exploring the interplay betweenFrontiers in microbiology · 2023
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lyudmila AkhmaltdinovaKaraganda Medical University, Karaganda, Kazakhstan.
Valentina SirotaKaraganda Medical University, Karaganda, Kazakhstan.
Dmitriy BabenkoKaraganda Medical University, Karaganda, Kazakhstan.
Vera ZhumaliyevaKaraganda Medical University, Karaganda, Kazakhstan.
Irina KadyrovaKaraganda Medical University, Karaganda, Kazakhstan.
Mereke MaratkyzyKaraganda Medical University, Karaganda, Kazakhstan.
Aigerim IbrayevaKaraganda Medical University, Karaganda, Kazakhstan.
Olga AvdienkoKaraganda Medical University, Karaganda, Kazakhstan.
Karaganda Medical University · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer is one of the most often diagnosed malignant tumors. In Kazakhstan, high incidence of CC is registered along with other oncology diseases. Despite a significant progress in the disease treatment achieved lately, CC is still one of the major reasons of mortality due to oncologic pathologies. To study the samples MilliplexMap HumanCirculationBiomarker panel in blood serum was used. XMap-based Fluorescence immunoassay was implemented, which comprised magnetic-bead-based simultaneous fluorescence detection of IL-6, IL-8, MIF, FGF-2, SCF, TGF, TNF, TRAIL analytes. Proinflammatory biomarker concentration detection at different CC stages allows to reveal the dynamics of inflammatory response of the organism to tumor and to use them (biomarkers) in further diagnostic and forecast in particular in CC. As a result of our study, it was found that IL-6, which showed the brightest reaction, due to its range of change and considerable shift already in the I stage can be recommended as a component of a complex diagnostic panel. Such markers as FGF2 and MIF also have a role in CC early stage detection.

Indexed as

cancer biomarkerscolorectal cancercytokineinflammationinterleukin

Identifiers

PMID33531866
PMCPMC7836277
OpenAlexW3125966131

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.